Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide effect on appetitive behavior in post-RYGB patients
NCT02010385Completed
- Sponsor
- University College Dublin
- Start
- Feb 2013
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of octreotide in obesity (2 arms), sponsored by University College Dublin. Primary endpoint: Progressive Ratio Breakpoint at 1 hour. Started Feb 2013; status: completed.
02
Drugs
octreotide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02010385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010385.